1,3,5-Tris[(3,3,3-trifluoropropyl)methyl]-cyclotrisiloxane, 99.00%, 100g

1-Bromoanthracene>97.0%(GC)500mg

1,1,3-Trimethyl-2,3-dihydro-1H-inden-4-amine hydrochloride, 97%, 250mg

6-Benzyl-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-3(2H)-one, 95.0%, 1g

4-Amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide, 98.0%, 5g

1-BROMO-4-(1,1-DIFLUOROPROPAN-2-YL)BENZENE, 95.0%, 250mg

Filtrationsgeräte mit SFCA-Membran, Ø 90 mm, Porengröße 0,2 µm, 500 ml, 12 Stück

11-Piperazin-1-yl-dibenzo[b,f][1,4]thiazepine dihydrochloride, 97.0%, 1g

4-Fluoro-3-(hydroxymethyl)phenol, 98%, 1g

2-(2-Aminoacetamido)-3-phenylpropanoic acid, 95.0%, 10g

DIMETHYL 4-HYDROXYPYRAZOLE-3,5-DICARBOXYLATE, 95%, 10g

1-Chloro-1-propene (cis- and trans- mixture)>90.0%(GC)10mL

2-(2-{[(benzyloxy)carbonyl]amino}-6-oxo-6,9-dihydro-1H-purin-9-yl)acetic acid, 98%, 1g